Literature DB >> 2328630

Improvement of anal sensation with preservation of the anal transition zone after ileoanal anastomosis for ulcerative colitis.

R Miller1, D C Bartolo, W J Orrom, N J Mortensen, A M Roe, F Cervero.   

Abstract

One of the most important considerations in restorative proctocolectomy for ulcerative colitis is postoperative continence. Preservation of the anal transition zone has been associated with improved results after this procedure in the pediatric age group. This study was carried out to determine the effect of preservation of the amal transition zone in adult patients undergoing restorative proctocolectomy, comparing a group of patients with the anal transition zone preserved with a group of patients with the anal transition zone removed. Physiologic testing demonstrated improved sensation in those patients with a preserved anal transition zone. Functional results were not significantly improved, although there was a trend toward improved continence and discrimination in those with the anal transition zone preserved. Although the results are early and are not conclusive from the clinical standpoint, they are certainly encouraging and may justify continued use of this technique.

Entities:  

Mesh:

Year:  1990        PMID: 2328630     DOI: 10.1007/bf02156269

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

Review 1.  The results of pouch surgery after ileo-anal anastomosis for inflammatory bowel disease: the manometric assessment of pouch continence and its reservoir function.

Authors:  M Pescatori
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

2.  Stapled ileoanal anastomosis for ulcerative colitis and familial polyposis without a temporary diverting ileostomy.

Authors:  H J Sugerman; H H Newsome; G Decosta; A M Zfass
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

3.  Anal transition zone in the surgical management of ulcerative colitis.

Authors:  Jennifer Holder-Murray; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

4.  Stapled ileal pouch-anal anastomosis with resection of the anal transition zone.

Authors:  J Braun; K H Treutner; V Schumpelick
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

Review 5.  Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.

Authors:  Alex Kartheuser; Pierre Stangherlin; Dimitri Brandt; Christophe Remue; Christine Sempoux
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

6.  Assessments of anal canal sensitivity in patients with soiling 5 years or more after colectomy, mucosal proctectomy, and ileal J pouch-anal anastomosis for ulcerative colitis.

Authors:  Ryouichi Tomita; Seigo Igarashi
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

7.  Pudendal nerve terminal motor latency in patients with or without soiling 5 years or more after low anterior resection for lower rectal cancer.

Authors:  Ryouichi Tomita; Seigo Igarashi; Taro Ikeda; Tsugumichi Koshinaga; Shigeru Fujisaki; Katsuhisa Tanjoh
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

Review 8.  Completion mucosectomy for retained rectal mucosa following restorative proctocolectomy with double-stapled ileal pouch-anal anastomosis.

Authors:  Maria E Litzendorf; Arthur F Stucchi; Susana Wishnia; Amy Lightner; James M Becker
Journal:  J Gastrointest Surg       Date:  2010-03       Impact factor: 3.452

Review 9.  Ileal pouch surgery for ulcerative colitis.

Authors:  Simon P Bach; Neil J Mortensen
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

10.  Preservation of the anal transition zone in ulcerative colitis. Long-term effects on defecatory function.

Authors:  Alessandro Fichera; Laura Ragauskaite; Mark T Silvestri; Nicholas M Elisseou; Michele A Rubin; Roger D Hurst; Fabrizio Michelassi
Journal:  J Gastrointest Surg       Date:  2007-09-29       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.